Extracapsular extension on multiparametric magnetic resonance imaging better predicts pT3 disease at radical prostatectomy compared to perineural invasion on biopsy

Authors

  • Luke Griffiths Northwell Health
  • Srinath Kotamarti Maimonides Medical Center, Brooklyn, NY, USA
  • David Mikhail Lenox Hill Hospital, Northwell Health, NY, USA https://orcid.org/0000-0003-4814-6095
  • Joseph Sarcona Department of Urology, Lenox Hill Hospital, New York, NY, USA
  • Ardeshir R. Rastinehad Department of Urology, Lenox Hill Hospital, New York, NY, USA
  • Robert Villani Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA
  • Jessica Kreshover Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA
  • Simon J. Hall Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA
  • Manish A. Vira Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA
  • Michael J. Schwartz Smith Institute for Urology, Northwell Health, New Hyde Park, NY, USA
  • Lee Richstone Department of Urology, Lenox Hill Hospital, New York, NY, USA

DOI:

https://doi.org/10.5489/cuaj.6909

Keywords:

ECE, PNI, MRI, pT3, Prostate Cancer, Upstaging, Radical prostatectomy

Abstract

Introduction: Risk assessment for non-organ-confined prostate cancer (PCa) is important in the surgical planning for radical prostatectomy (RP). Perineural invasion (PNI) on prostate biopsy has been associated with adverse pathological outcomes at prostatectomy. Similarly, the identification of suspected extracapsular extension (ECE) on multiparametric magnetic resonance imaging (mpMRI) has been shown to predict non-organ-confined disease. However, no prior study has compared these factors in predicting adverse pathology at prostatectomy. We evaluated mpMRI ECE and prostate biopsy PNI on multivariable analysis to determine their ability to predict pathological stage at time of RP.

Methods: We retrospectively investigated the prostatectomy database at our institution to identify men who underwent prostate biopsy with pre-biopsy mpMRI and subsequent RP from 2013– 2017. Multivariable regression analysis was performed to compare the association of mpMRI ECE (mECE) and PNI on prostate biopsy on the likelihood of finding pT3 disease on pathology post-prostatectomy.

Results: Of a total 454 RP between 2013 and 2017, 191 patients met our inclusion criteria. Stage pT2 and pT3+ were found in 120 (62.8%) and 71 (37.2%) patients, respectively. Patients with mECE had 4.84 cumulative odds of worse pathological stage on RP (p=0.045) compared to PNI on biopsy, which showed cumulative odds of 2.25 (p=0.048). When controlling only for those patients without PNI, mECE was still found to be a significant predictor of pT3 disease at RP (p=0.030); however, in patients without mECE, PNI was not significant (p=0.062).

Conclusions: While mECE and biopsy PNI were both associated with worse pathological stage on RP, mECE had significantly higher cumulative odds compared to PNI. The significant predictive ability of mECE adds further clinical value to the use of mpMRI in PCa management. While validation in a larger cohort is required, these factors have important clinical implications with regards to early diagnosis of advanced disease and surgical planning.

Downloads

Download data is not yet available.

Downloads

Published

2021-01-04

How to Cite

Griffiths, L., Kotamarti, S., Mikhail, D., Sarcona, J., Rastinehad, A. R., Villani, R., Kreshover, J., Hall, S. J., Vira, M. A., Schwartz, M. J., & Richstone, L. (2021). Extracapsular extension on multiparametric magnetic resonance imaging better predicts pT3 disease at radical prostatectomy compared to perineural invasion on biopsy. Canadian Urological Association Journal, 15(8), 261–6. https://doi.org/10.5489/cuaj.6909

Issue

Vol. 15 No. 8 (2021): CUAJ August

Section

Original Research

License

You, the Author(s), assign your copyright in and to the Article to the Canadian Urological Association. This means that you may not, without the prior written permission of the CUA:

  • Post the Article on any Web site
  • Translate or authorize a translation of the Article
  • Copy or otherwise reproduce the Article, in any format, beyond what is permitted under Canadian copyright law, or authorize others to do so
  • Copy or otherwise reproduce portions of the Article, including tables and figures, beyond what is permitted under Canadian copyright law, or authorize others to do so.

The CUA encourages use for non-commercial educational purposes and will not unreasonably deny any such permission request.

You retain your moral rights in and to the Article. This means that the CUA may not assert its copyright in such a way that would negatively reflect on your reputation or your right to be associated with the Article.

The CUA also requires you to warrant the following:

  • That you are the Author(s) and sole owner(s), that the Article is original and unpublished and that you have not previously assigned copyright or granted a licence to any other third party;
  • That all individuals who have made a substantive contribution to the article are acknowledged;
  • That the Article does not infringe any proprietary right of any third party and that you have received the permissions necessary to include the work of others in the Article; and
  • That the Article does not libel or violate the privacy rights of any third party.